Related Experiment Video
Updated: Aug 2, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Ototoxicity of common topical antimycotic preparations
1Department of Pediatric Otolaryngology, The Children's Hospital of Philadelphia, Pennsylvania 19104-4399, USA.
Objective:
To determine the ototoxic effects of five commonly used topical antimycotic agents-clotrimazole, miconazole, nystatin, tolnaftate, and gentian violet-in the guinea pig.
Design:
A controlled animal study in which the ototoxicity of commonly used topical antifungal agents was investigated by measurement of hair cell loss.
Methods:
Several readily available topical antimycotic preparations were instilled into the middle ears of female Hartley guinea pigs over a 1-week period. Two weeks after the last instillation, the animals were euthanized. An active control group was treated with neomycin to confirm the adequacy of the treatment in delivering a known ototoxin; an untreated control group defined the normal distribution of hair cells. The temporal bones were removed, and the cochleas were fixed and dissected. The basilar membranes were examined under the scanning electron microscope. A map of hair cell survival was made for each row in segments of each turn.
Results:
The untreated control animals had no discernible hair cell loss in the two lower turns. In the apical turn and sometimes the third turn, loss of hair cells was a common finding, this is a known effect of aging in this species. The animals treated with neomycin had damage consistently in the basal turn, sometimes extending into the second turn, as well as the expected hair cell loss in the apical turn. Clotrimazole, miconazole, or tolnaftate did not cause any hair cell loss in the first two turns. Hair cell loss in the third and fourth turns was similar to that of the untreated control group. Likewise, nystatin exhibited no evidence of ototoxicity. Of note, however, the preparation used in this study left a persistent residue in the round window niche. Of the first four animals treated with gentian violet, three developed pronounced behavioral signs of vestibular damage, and three demonstrated extensive middle ear inflammation and extensive new bone growth. Hair cell counts were not attempted because the extreme bone growth interfered with successful perfusion and dissection.
Conclusions:
Extrapolating from guinea pigs to humans requires caution. However, it is likely that guinea pigs are, if anything, more susceptible to topical ototoxins than are humans. The specific antimycotics clotrimazole, miconazole, and tolnaftate appear to be safe. Gentian violet has the potential for severe damage. The persistent residue left by the nystatin preparation is cause for concern and is a reminder that both the active ingredient and vehicle must be considered in evaluation of safety.
Insights
Clotrimazole, miconazole, and tolnaftate are safe topical antifungal agents, while gentian violet may cause severe damage. Nystatin showed no ototoxicity but left concerning residue. Guinea pigs are more susceptible to ototoxins than humans.
Area of Science:
- Ototoxicology
- Pharmacology
- Veterinary Medicine
Background:
- Topical antimycotic agents are widely used, necessitating an understanding of their potential ototoxicity.
- The ototoxic effects of commonly used agents like clotrimazole, miconazole, nystatin, tolnaftate, and gentian violet require thorough investigation.
Purpose of the Study:
- To evaluate the ototoxic potential of five common topical antifungal medications in a guinea pig model.
- To compare the safety profiles of clotrimazole, miconazole, nystatin, tolnaftate, and gentian violet regarding inner ear health.
Main Methods:
- A controlled animal study involving the topical application of five antimycotic agents to the middle ears of guinea pigs.
- Hair cell loss in the cochlea was assessed using scanning electron microscopy after a 1-week treatment period and a 2-week observation period.
- Included active (neomycin) and untreated control groups to validate the methodology and establish baseline hair cell distribution.
Main Results:
- Clotrimazole, miconazole, and tolnaftate did not induce hair cell loss in the basal and middle turns of the cochlea.
- Nystatin showed no ototoxicity, but its preparation left a residue in the round window niche.
- Gentian violet treatment resulted in severe vestibular and middle ear inflammation, with extensive bone growth precluding hair cell analysis.
Conclusions:
- Clotrimazole, miconazole, and tolnaftate are likely safe for otologic use, with guinea pigs being more susceptible to ototoxins than humans.
- Gentian violet poses a risk of severe ototoxicity and middle ear damage.
- The vehicle of topical preparations, as exemplified by nystatin, warrants careful consideration for potential adverse effects beyond the active ingredient.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Antimicrobial Effectiveness
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

